08/29/2013
Ellen Patterson spent her summer as a cancer research intern at Providence Cancer Center after successfully battling ovarian cancer at 15. More>>
05/16/2013
Finding effective treatments for the various types of cancer – it’s the goal of researchers around the world, and right here in Portland. Now Providen More>>
04/02/2013
The donation is a result of the store chain's third quarter employee giving campaign and all the coins collected in the checkout lines at Portland are More>>
03/29/2013
Dr. Walter Urba, director of cancer research for Providence's Robert W. Franz Cancer Research Center, comments on experimental immunotherapy treatment More>>
03/15/2013
Patients with advanced melanoma are getting a boost from work being done at Providence, thanks to a grant from the National Institutes of Health. More>>
3/11/2013
In the past 20 years, Providence has contributed to several significant breakthroughs in cancer research. More>>
01/14/2013
Funds from Safeway's "round up" at the checkout counters will be divided among four areas of breast cancer research at Providence. More>>
12/06/2012
Research scientist Keith Bahjat, Ph.D., recently received two grants supporting work on immunotherapy. More>>
09/28/2012
Providence is the only cancer facility in Oregon to receive QOPI certification. More>>
06/06/2012
Providence Cancer Center researchers study a unique approach, combining radiation and immunotherapy treatments. More>>
06/04/2012
"There is still a long road ahead, but now it's lined with some successes," says Walter Urba, M.D., Ph.D. More>>
05/08/2012
Safeway customers and employees in Oregon and Southwest Washington raised $500,000 for breast cancer awareness, treatment and research at Providence. More>>
04/30/2012
04/26/2012
Read the latest highlights on our researchers. More>>
Providence Cancer Center researcher Michael Gough, Ph.D., has received a Career Catalyst Research Grant from Susan G. Komen for the Cure to study the More>>
12/02/2011
The biotech company will fund further OX40 research developed by Providence scientists. More>>
04/11/2011
Ipilimumab is the first drug shown to extend survival in patients with late-stage melanoma. More>>
Enter your ZIP to see local news and info